SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-018892
Filing Date
2018-08-02
Accepted
2018-08-02 16:08:14
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnat-10q_20180630.htm 10-Q 890001
2 EX-1.1 cnat-ex11_158.htm EX-1.1 375340
3 EX-5.1 cnat-ex51_291.htm EX-5.1 32194
4 EX-31.1 cnat-ex311_7.htm EX-31.1 10756
5 EX-31.2 cnat-ex312_9.htm EX-31.2 10802
6 EX-32.1 cnat-ex321_6.htm EX-32.1 6836
7 EX-32.2 cnat-ex322_8.htm EX-32.2 6922
8 GRAPHIC gnm5y2upaj0w000001.jpg GRAPHIC 2450
9 GRAPHIC gnm5y2upaj0w000002.jpg GRAPHIC 58309
  Complete submission text file 0001564590-18-018892.txt   4153804

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT cnat-20180630.xml EX-101.INS 703217
11 XBRL TAXONOMY EXTENSION SCHEMA cnat-20180630.xsd EX-101.SCH 33042
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnat-20180630_cal.xml EX-101.CAL 36000
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnat-20180630_def.xml EX-101.DEF 98868
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnat-20180630_lab.xml EX-101.LAB 276310
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnat-20180630_pre.xml EX-101.PRE 199895
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36003 | Film No.: 18988327
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1